FDA Investigator Emily J Orban

Emily J Orban has inspections in 11 countries as of 06 Oct 2023. Emily J Orban has collaborated with a combinined 6282 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
148
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100002123
Country:
United States of America, Canada, Italy, Spain, Germany, Hungary, Sweden, Switzerland, Netherlands, Belgium
Co-Investigator(s):
Abdul K Kamara, Abuzar Shamim, Adaliz Santaliz Cruz, Adam J Wilson, Adam R Cooke, Alan M Barker, Alan M Roberts, Alanna Lmussawwir Bias, Alexandra A Carrico, Amy S Graf, Anastasia M Shields, Andrace Lde Yampert, Andrea D Swingle, Andrea F White, Angela E Glenn, Anita Narula, PhD, Ann Raju Daniel, Anne Marie Russell, Anthony C Warchut, Anthony F Lorenzo, Anthony R Petriella, Armando Morales, Art O Czabaniuk, Ashley E Lewis, Aurora Miha Trifanov, Aurora Mihaela Trifanov, Ava M Bowman, Azza Talaat, Barbara A Rusin, Bei Y He, Benjamin J Smith, Bleta Vuniqi, Brant M Schroeder, Brent M Dehaan, Brentley S Collins, Brian J Mundo, Brian M Campbell, Brian P Putz, Bruce, Burnell M Henry, Byron Ho, DVM, Byungja E Marciante, Calvin K Cook, Camerson E Moore, Carmen M Faraianu, Caroline H Le, Carolyn J Oyster, Catherine J Laufmann, Catherine V Quinlan, Cathie S Marshall, CDR Ileana Barreto Pettit, Charisse K Green, Charles I Ann, Charles L Zhou, Charles M Edwards, Charles M Spyr, Chelsea J Falkowski, Chelsea J Snider, Cheng H Yen, Cheryl A Fuhs, Cheryl M Monroe, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christine J Watts, Constantin Y Philopoulos, Corrine M Carter, Courtney E Hillier, Crystal L Parks, Crystal M Young Lewis, Cynthia L Aycock, Cynthia Li, Danial S Hutchison, Daniel J Brown, Daniel J Gorski, Daniel J Grabicki, Daniel L Obrzut, Danny Tuntevski, Darren S Brown, Darren S Morgan, David A Paterson, David J Gasparovich, David J Gsparovich, David M Beltran, David Perkins, Dawn C Olenjack, Deanna L Lampley, Deanne Lampley, Debara R Reese, Debara Reese, Deborah M Trout, Demitria J Xiradakis, Denise L Burosh, Denise M Digiulio, Denise R Beuttenmuller, Dennis E Guilfoyle, PhD, Dennis E Swartz, Dina A Tallman, Donald C Obenhuber, PhD, Donald L Lech, Donald W Myrick, Donna Ltartaglino Besone, Downer, Dr. Barbara D Paul, PhD, Eboni S Funderburk, Eliezar Ramos, Emest F Bizjak, Emiklie E Kahn, Emilie E Kahn, Emilie E, Kahn, Enrico Joset Mangahis, Eric S Pittman, Erica N Koory, Erika V Butler, Erin M Miller, Franklin D Heisler, French, Gam S Zamil, Gary C Pecic, Gary Durbiel Goldner, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, George G Calafactor, Gerald B Seaborn, Jr, Gregory A Cronce, Hans T Meyers, Hartman, Helen B Ricalde, Hokenson, Ifueko Osemwota, Ina M Pawlowski, Jacob A Clark, Jacob G Lutz, Jacqueline Mdiaz Albertini, Jagan Mohanr Parepally, PhD, James A Beaulieu, James E Szelc, James K Ireland, James R Evans, Janet L Bowen, Janice L King, Jason F Chancey, Jean Blackston Hill, Jean Blackstone Hill, Jeffery A Hangartner, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer L Schmidt, John N Woodall, Joneson, Joohi Castelvetere, Jose Acruz Gonzalez, Jose R Hernandez, Joseph A Piechocki, Joseph R Haynes, Joseph R Strelnik, Joseph T Madak, Joshua J Silvestri, Justin A Boyd, Justin M Tomczak, Karen M Montgomery (KMM), Kathryn A Guardiola, Kathryn E Ogger, Kathryn G Brown, Kelley L Clark, Kenneth A Day, Kenneth E Felkley, Kham Phommachanh, Kimberly Lewandowski Walker, Kinh Q Mac, Kip R Meleski, Kristina Mezin, Kristina Nastovski, Kristy A Zielny, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Burke, Lauren E Sexton, Lauren Iacono Connors, PhD, Lauren M Lilly, PhD, Laurie B Frazier, LCDR Anastasia Mpiliafas Brown, LCDR Chad N Thompson, Leigh Anne Myers, Leslie A Paul, Liming Zhang, Linda S Jozefiak, Lindsey Brown, PhD, Lindsey M Schwierjohann, Lindsey S Fleischman, Lisa J Joseph, Lisa M Bellows, Lisa M Thursam, Lisa P Oakes, Lisa T Michel, Logan M Ebeling, Logan T Williams, LT Skip A Payne, Luella J Rossi, Luis A Dasta, Makini Cobourne Duval, PhD, Margaret N Persich, Maria C Iuga, Mark R Mcclain, Marlon K Turner, Martha Sullivan Mynck, Martha Sullivan Myricj, Martha Sullivan Myrick, Martin L Cohen, Martin R Vowell, Matthew J Gretkierewicz, Megan C Amye, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Miah I Schneider, Michael A Moutray, Michael R Goga, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Michelle L Jones, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Monica L Hughes, Montgomery Montgomery, Karen M, Mra Mcculloughj, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy A Bellamy, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nicholas E Boyd, Nicholas J Presto, Omotunde O Osunsanmi, Owens, Paige E Shelborne, Paranthaman Senthamaraikannan, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy I Domingo, Patsy J Domingo, Paula A Trost, Peng Zhou, Phenicia T Petty, Phenicia T Wedgeworth, Philip A Klimkewicz, Prabhu P Raju, Pratik S Upadhyay, DDC, Qiao Y Bobo, Rabin N Ghoshal, Rafeeq A Habeeb, Ralph A Erickson, Rasha Bamieh, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Regina T Brown, Reginald Walker, Renee L Rice, PhD, Richard K Vogel, Richard Ledwidge (nmi), PhD, Richard W Thornton, Robert C Coleman, Robert D Tollefsen, Robert G Taylor, Robert J Doyle, Robert J Ham, Robert M Barbosa, Robert P Whisenant, Robert R Barbosa, Roger A Hartman, Rohn R Robertson, Ronald G Crawford, Rose M Ashley, Ryan J Benedict, Salwa K Poole, Samuel H Chan, PharmD, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah B Tanksley, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott T Ballard, Sean R Bryd, Sharon K Thoma, PharmD, Sherri J Jackson, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, State Agency, Steven R Ziser, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Suyang Qin, Tamil Arasu, PhD, Temar Q Williams, Thanh M Andrews, Theodore N Sietsema, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracey L Taylor, Truong Xuan Nguyen (Andy), Ucheabuchi C Chudi Nwankwor, Vanessa J Colburn, Vesa Vuniqi, Wayne E Seifert, William A Warnick, William C Gilbert, William D Tingley, William G Nelson, William R Brubaker, Xiaohui Shen, Xikui Chen (nmi), PhD, Yangmin Ning, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Zachary L Miller

Emily J Orban's Documents

Publish Date Document Type Title
June, 2012 FDA 483 King Pharmaceuticals LLC - Form 483, 2012-06-15
March, 2014 FDA 483 Pharmakon Pharmaceuticals, Inc. - Form 483, 2014-03-13
April, 2017 FDA 483 Accra Pac, Inc. dba Voyant Beauty - Form 483, 2017-04-05
November, 2018 FDA 483 Response DDP Specialty Electronic Materials US 9, LLC - Form 483R, 2018-11-21
November, 2015 EIR Ash Stevens LLC - EIR, 2015-11-02
February, 2018 FDA 483 Response Lannett Company, Inc. - Form 483R, 2018-02-16
January, 2014 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2014-01-14
January, 2017 EIR Linde Gas & Equipment Inc. - EIR, 2017-01-12
March, 2017 FDA 483 Par Sterile Products LLC - Form 483, 2017-03-13
October, 2012 FDA 483 Enzyme Solutions, Inc. - Form 483, 2012-10-31
September, 2012 FDA 483 Elba, Inc. - Form 483, 2012-09-27
January, 2019 FDA 483 L. Perrigo Company - Form 483, 2019-01-17
February, 2018 EIR Lannett Company, Inc. - EIR, 2018-02-02
November, 2018 FDA 483 DDP Specialty Electronic Materials US 9, LLC - Form 483, 2018-11-07
November, 2014 FDA 483 Response Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483R, 2014-11-13
September, 2013 EIR Linde Inc. - EIR, 2013-09-25
March, 2016 FDA 483 Pharmakon Pharmaceuticals, Inc. - Form 483, 2016-03-16
December, 2010 FDA 483 Response Cayman Chemical Company, Inc. - Form 483R, 2011-03-01
December, 2016 FDA 483 Huron Pharmaceuticals, Inc. - Form 483, 2016-12-22
April, 2014 FDA 483 Zoetis LLC - Form 483, 2014-04-17
May, 2013 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2013-05-30
March, 2017 FDA 483 Response Par Sterile Products LLC - Form 483R, 2017-03-31
March, 2019 FDA 483 Division of Nuclear Medicine PET Radiopharmaceutical Production Program - Form 483, 2019-03-07
November, 2017 FDA 483 Diplomat Pharmacy Inc. dba Diplomat Specialty Pharmacy - Form 483, 2017-11-17
June, 2012 EIR King Pharmaceuticals LLC - EIR, 2012-06-15
November, 2018 EIR DDP Specialty Electronic Materials US 9, LLC - EIR, 2018-11-07
February, 2018 FDA 483 Lannett Company, Inc. - Form 483, 2018-02-02
February, 2013 EIR Cayman Chemical Company, Inc. - EIR, 2013-02-28
January, 2017 FDA 483 Linde Gas & Equipment Inc. - Form 483, 2017-01-12
January, 2016 FDA 483 Response Clark Professional Pharmacy, LLC - Form 483R, 2016-02-11
December, 2012 FDA 483 Par Sterile Products LLC - Form 483, 2012-12-28
May, 2016 FDA 483 Pharmakon Long Term Care Pharmacy, Inc. - Form 483, 2016-05-11
March, 2019 FDA 483 Response Division of Nuclear Medicine PET Radiopharmaceutical Production Program - Form 483R, 2019-03-28
December, 2012 EIR Par Sterile Products LLC - EIR, 2012-12-28
September, 2011 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2011-09-23
August, 2010 FDA 483 Aurorium LLC - Form 483, 2010-08-27
December, 2018 FDA 483 Michigan Medicine - Form 483, 2018-12-14
January, 2014 EIR DDP Specialty Electronic Materials US 9, LLC - EIR, 2014-01-24
September, 2015 EIR Par Sterile Products LLC - EIR, 2015-09-10
November, 2014 FDA 483 Ash Stevens LLC - Form 483, 2014-11-24
June, 2013 EIR Pharmacia & Upjohn Company LLC - EIR, 2013-06-21
March, 2018 FDA 483 Element Materials Technology Ann Arbor LLC - Form 483, 2018-03-22
September, 2017 FDA 483 KDC/ONE Development Corporation, Inc - Form 483, 2017-09-21
November, 2014 FDA 483 Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483, 2014-11-13
December, 2010 EIR Cayman Chemical Company, Inc. - EIR, 2010-12-15
February, 2014 FDA 483 Par Sterile Products LLC - Form 483, 2014-02-10
October, 2013 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2013-10-09
March, 2011 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2011-03-25
September, 2018 EIR Pharmacia & Upjohn Company LLC - EIR, 2018-09-21
November, 2011 FDA 483 Painexx Corporation - Form 483, 2011-11-09
February, 2013 FDA 483 Cayman Chemical Company, Inc. - Form 483, 2013-02-28
March, 2019 EIR Division of Nuclear Medicine PET Radiopharmaceutical Production Program - EIR, 2019-03-07
September, 2018 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2018-09-21
September, 2013 FDA 483 Linde Inc. - Form 483, 2013-09-25
June, 2016 EIR Corteva Agriscience LLC - EIR, 2016-06-08
November, 2013 FDA 483 Corden Pharma Bergamo SpA - Form 483, 2013-11-08
September, 2014 FDA 483 L. Perrigo Company - Form 483, 2014-09-16
August, 2012 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2012-08-29
July, 2018 FDA 483 Ionetix Corporation - Form 483, 2018-07-02
June, 2013 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2013-06-20
June, 2010 FDA 483 Vortech Pharmaceuticals, Ltd. - Form 483, 2010-06-28
April, 2018 FDA 483 Curium US LLC - Form 483, 2018-04-06
September, 2018 EIR Pharmacia & Upjohn Company LLC - EIR, 2018-12-10
January, 2016 FDA 483 Clark Professional Pharmacy, LLC - Form 483, 2016-01-29
August, 2014 FDA 483 King Pharmaceuticals LLC - Form 483, 2014-08-26
April, 2017 FDA 483 Response Accra Pac, Inc. dba Voyant Beauty - Form 483R, 2017-04-24
July, 2017 FDA 483 Tri-Med, Inc. dba Advanced Care Infusion-Shelby - Form 483, 2017-07-11
March, 2017 EIR Par Sterile Products LLC - EIR, 2017-03-13
December, 2016 FDA 483 Response Huron Pharmaceuticals, Inc. - Form 483R, 2017-05-16
September, 2015 FDA 483 Par Sterile Products LLC - Form 483, 2015-09-10
December, 2012 FDA 483 Response Par Sterile Products LLC - Form 483R, 2013-01-22
June, 2016 EIR Element Materials Technology Ann Arbor LLC - EIR, 2016-06-28
January, 2014 FDA 483 DDP Specialty Electronic Materials US 9, LLC - Form 483, 2014-01-24
March, 2016 EIR Pharmakon Pharmaceuticals, Inc. - EIR, 2016-03-16
May, 2018 FDA 483 Sanofi S.r.l. - Form 483, 2018-05-31
November, 2016 FDA 483 King Pharmaceuticals LLC - Form 483, 2016-11-21
December, 2010 FDA 483 Cayman Chemical Company, Inc. - Form 483, 2010-12-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more